If participants from other institutions not having an IRB (e.g., hospitals, schools, businesses) comprise all or part of the population for this study, written approval should be obtained from an authorized official of that institution. A statement of preliminary contacts with the appropriate officials should be attached to materials submitted for review. If the other institution has an IRB, attach a copy of its approval for the activities to be carried out at that institution.
If the research is federally funded, the UAB OIRB must determine if the other institution is “engaged in research’ as stated in 45 CFR 46.103 and defined in OHRP guidance of January 26, 1999. If the other institution is engaged in research, then it must have (a) an assurance with OHRP and (b) IRB approval from its registered IRB.
For research that is conducted at the VA only, with no funding through the UAB Office of Sponsored Programs (OSP), and under a VA appointment, the protocol does not have to be submitted to the UAB IRB. Contact the VA Research Compliance Officer for information regarding the regulations on submitting to their office. The contact person is Kim Moses, Research Compliance Officer and Program Analyst, at 933-8101 ext. 5176.
For research that is conducted at both the VA and UAB or with funding through the UAB OSP, the protocol must be submitted to both the VA IRB and UAB IRB. The UAB IRB will require that you provide a copy of the VA IRB approval and VA IRB-stamped consent form(s). Dually-stamped consent forms are no longer permissible at the VA. Please contact the VA if you are interested in conducting research at both UAB and the VA.
If the study is being conducted at University of Alabama Hospital, UAB Highlands, The Kirklin Clinic, Callahan Eye Foundation Hospital, or Children´s of Alabama, notify the appropriate official (listed below) by e-mail, or phone if listed, and include the contact's confirmation with your application.
For studies using UA Hospital and/or UAB Highlands, before applying to the IRB, notify Ivy (Eivora) Cook, Manager Patient Financial Services by e-mail (firstname.lastname@example.org) or phone (975-6938 or 934-6400) of the study's PI, Title, Coordinator, Coordinator telephone number, Department, and Sponsor. Include confirmation of receipt with application.
For studies using TKC, before applying to the IRB, notify Frances Clark, by e-mail (email@example.com) or phone (801-8707) of the study's PI, Title, Coordinator, Coordinator telephone number, Department, and Sponsor. Include reply confirmation with application.
For using CEFH, before applying to the IRB, notify Leigh Aufdemorte by e-mail (firstname.lastname@example.org) of the PI, Study Title, Study Coordinator, Department, and Sponsor of the study. Include the reply e-mail approval with application.
For studies using Children's, notify Pam Barlow in Administration by e-mail (Pam.Barlow@childrensal.org) of the study's PI, Title, Coordinator, Department, and Sponsor. Include the confirmation number and e-mail reply with application. See also “Policies Concerning Drugs for Research Use.”
For studies using the CRU, notify Dr. Kathleen B. Powell by e-mail (email@example.com) of the study's PI, Title, Coordinator, Department, and Sponsor. Include the e-mail confirmation with application.
Page updated: August 26, 2013